Novel HMG-COA reductase inhibitors
US4992429A · kind A · utility
19Cited by
7References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 1989 |
| Grant date | Feb 12, 1991 |
| Priority date | — |
| Expiry date | Aug 24, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/3223
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel substituted cyclohexenyl phosphinylhydroxybutyrates as 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula: ##STR1## and pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.